Transdermal patch

DRUG3 trials

Sponsors

Daiichi Sankyo Brasil Farmacêutica LTDA, Washington University School of Medicine, Medical College of Wisconsin

Conditions

Clotting DisorderPainTransgenderismTrauma

Early Phase 1

Coagulation and Fibrinolysis of Estradiol in Transwomen

TerminatedNCT05387577

Medical College of WisconsinClotting Disorder, Transgenderism

Start: 2021-12-07End: 2022-11-23Updated: 2022-12-21

Phase 2

Transgender Estradiol Affirming Therapy

CompletedNCT05010707

Washington University School of MedicineTransgenderism

Start: 2021-08-02End: 2024-01-01Updated: 2024-11-26

Phase 3

Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma

CompletedNCT02616068

Daiichi Sankyo Brasil Farmacêutica LTDAPain, Trauma

Start: 2015-10-31End: 2016-12-31Updated: 2017-02-14

Related Papers

Effectiveness and Safety of Different Estradiol Regimens in Transgender Women (TREAT Study): Protocol for a Randomized Controlled Trial

JMIR Research Protocols2023-11-032 citations